Clinical Trial Update: SFX-01 After Subarachnoid Haemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial update for SFX-01 in spontaneous subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• SFX-01

Snippet

Sponsor: Evgen Pharma | Conditions: Subarachnoid Hemorrhage, Spontaneous | Phase 2 | Status: COMPLETED